- Multianalyte Blood Immunoassays with algorithmic analyses.
- Gene expression profiling to identify cancer regulation phenotype and metastasis risk
Beyond traditional laboratory testing
Persona Biomed is building a next-generation precision diagnostics and clinical-intelligence platform designed to move medicine from static, organ-centric testing toward system-level molecular insight. The company’s core thesis is that disease begins and evolves at the molecular-systems level long before abnormalities appear on routine laboratory tests or imaging, and that clinicians today need tools that translate those early molecular disturbances into actionable clinical intelligence. Persona Biomed aims to fill this gap by combining blood-based laboratory-developed tests, multi-analyte biomarker panels, composite biomarker indices, and AI-assisted clinical interpretation into an integrated diagnostic and decision-support platform.
AI-assisted interpretation of inter-organ molecular communication axes
Rather than functioning as a conventional specialty laboratory that reports isolated biomarkers, Persona Biomed positions itself as a complementary diagnostics platform that bridges laboratory data, imaging, and clinical decision-making. Its technology interprets inter-organ molecular communication networks across major biological axes, including the blood–brain barrier neurovascular axis, the immunometabolic axis, the angiofibrogenic cardioremodeling axis, the brain-bone axis and the gut–to–brain hepatopulmonary axis. The company’s service portfolio spans both non-oncology and oncology applications, including tests for blood–brain barrier neurovulnerability, cardioremodeling risk, obese immunometabolic subtypes, osteoporosis subtypes, multisystem foundational health, and transcriptional immunocarcinogenic profiling across major malignancies. Persona Biomed’s differentiation rests on three elements: cross-organ axis integration, composite biomarker indices that score multiple disease-relevant molecular pathways simultaneously, and a proprietary AI-driven interpretation engine that converts complex molecular data into clinically interpretable reports, disease phenotypes and endotypes, risk stratification, and treatment guidance.
Supporting Precision medicine practice
Persona Biomed is not selling raw laboratory outputs. It is selling interpretation and clinical intelligence layered on top of molecular profiling and phenotyping. Its intellectual property around biomarker combinations and interpretation algorithms and integrated clinical outcome scores is positioning the laboratory platform as more than a collection of standalone assays, with a business model structured as a hybrid diagnostics-and-data platform that merges traditional wet-lab molecular data with AI-assisted dry-lab data analytics, transforming the business from a service provider into an intelligence platform for better practicing Precision medicine in a broad variety of clinical specialties.
Company Management & Organization
Persona Biomed’s leadership combines decades of expertise in molecular diagnostics, biotechnology, artificial intelligence, and clinical practice. Each leader shares a common vision: a healthcare system where data drives decisions and patients are active participants in their care. A powerhouse team is blending biotech innovation, regulatory savvy, and scientific rigor, while maintaining a flexible organization for efficient scalability and regional expansion with affiliate programs for physician and clinics integration.
Persona Biomed operates as a nimble, globally minded precision medicine service company headquartered in Alexandria, VA, with a key presence in Spain.
It also operates as an affiliate microsite model enabling regional partners to deliver locally branded precision medicine services using Persona Biomed’s centralized technology, ensuring consistent quality and innovation across markets. Moreover, it is also expanding its reach throughout the Americas, including the southern regions (Bolivia, Peru and Chile).
Corporate Office sets strategic direction, governance, and cross-functional synergy between our U.S. and Spanish operations.
Operating Divisions allowing focused performance while maintaining overarching strategic cohesion
- Corporate Planning and Support – Oversight of vision, organizational alignment, partnership agreements, company's finances, Human Resources, Regulatory Affairs and compliance regarding data privacy (like HIPAA and GDPR), FDA guidelines for LDTs and ethical guidelines for handling patient data, and Legal/Intellectual Property.
- Business Development – Drives licensing agreements, Marketing and Sales.
- Clinical Research and Development – Drives biomarker research, clinical applications and precision medicine deployment.
- Laboratory Operations – Manages laboratory innovation, clinical sample processing and quality control/assurance.
- Educational Services & Digital Products – Delivers precision medicine training, patient/provider onboarding, portal management, and eCommerce functionality.
- Biomarker Analytics and Clinical AI: Supports laboratory report automation, biomarker interpretation, precision medicine interactive simulation and clinical data management.